Privium Fund Management B.V.
Latest statistics and disclosures from Privium Fund Management B.V.'s latest quarterly 13F-HR filing:
- Top 5 stock holdings are TSLA, SHOP, SPOT, PLTR, AMZN, and represent 50.03% of Privium Fund Management B.V.'s stock portfolio.
- Added to shares of these 10 stocks: LMND (+$7.3M), IREN (+$5.7M), VRDN (+$5.4M), BIIB, ENGN, ASTS, STOK, RARE, BNTX, RNAC.
- Started 6 new stock positions in RNAC, NOMD, STOK, ENGN, SRPT, VRDN.
- Reduced shares in these 10 stocks: SPOT (-$16M), TSLA (-$7.0M), AMZN (-$6.5M), ARWR (-$5.0M), MRK, SE, ABVX, RNA, ROIV, ACAD.
- Sold out of its positions in ALXO, ABVX, ACAD, RNA, PAAS, RXRX, SBSW, ROIV.
- Privium Fund Management B.V. was a net seller of stock by $-14M.
- Privium Fund Management B.V. has $543M in assets under management (AUM), dropping by -2.36%.
- Central Index Key (CIK): 0001795097
Tip: Access up to 7 years of quarterly data
Positions held by Privium Fund Management B.V. consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Privium Fund Management B.V.
Privium Fund Management B.V. holds 57 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Tesla Motors (TSLA) | 18.9 | $103M | -6% | 229k | 449.72 |
|
| Shopify Cl A Sub Vtg Shs (SHOP) | 12.2 | $66M | 410k | 160.97 |
|
|
| Spotify Technology S A SHS (SPOT) | 7.3 | $40M | -28% | 68k | 580.71 |
|
| Palantir Technologies Cl A (PLTR) | 6.5 | $36M | 200k | 177.75 |
|
|
| Amazon (AMZN) | 5.1 | $28M | -18% | 121k | 230.82 |
|
| Arrowhead Pharmaceuticals (ARWR) | 4.9 | $26M | -15% | 398k | 66.39 |
|
| Ionis Pharmaceuticals (IONS) | 3.5 | $19M | -3% | 241k | 79.11 |
|
| Coinbase Global Com Cl A (COIN) | 3.3 | $18M | 79k | 226.14 |
|
|
| Lemonade (LMND) | 3.3 | $18M | +71% | 248k | 71.18 |
|
| Sea Sponsord Ads (SE) | 3.2 | $18M | -13% | 138k | 127.57 |
|
| NVIDIA Corporation (NVDA) | 2.8 | $15M | 81k | 186.50 |
|
|
| Biogen Idec (BIIB) | 2.4 | $13M | +41% | 74k | 175.99 |
|
| Advanced Micro Devices (AMD) | 2.4 | $13M | 60k | 214.16 |
|
|
| Proqr Thrapeutics N V Shs Euro (PRQR) | 2.0 | $11M | +7% | 5.4M | 2.02 |
|
| Iren Ordinary Shares (IREN) | 1.9 | $11M | +115% | 280k | 37.77 |
|
| Ast Spacemobile Com Cl A (ASTS) | 1.9 | $11M | +31% | 145k | 72.63 |
|
| Axsome Therapeutics (AXSM) | 1.9 | $10M | +7% | 57k | 182.64 |
|
| Uniqure Nv SHS (QURE) | 1.8 | $10M | +7% | 416k | 23.93 |
|
| Arcutis Biotherapeutics (ARQT) | 1.6 | $8.9M | 306k | 29.04 |
|
|
| Ultragenyx Pharmaceutical (RARE) | 1.5 | $8.2M | +23% | 358k | 23.00 |
|
| Miragen Therapeutics (VRDN) | 1.0 | $5.4M | NEW | 174k | 31.12 |
|
| Urogen Pharma (URGN) | 0.9 | $5.0M | +9% | 215k | 23.42 |
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.8 | $4.2M | +12% | 9.4k | 453.36 |
|
| Merck & Co (MRK) | 0.7 | $3.9M | -43% | 37k | 105.26 |
|
| Wave Life Sciences SHS (WVE) | 0.6 | $3.3M | +13% | 193k | 17.00 |
|
| Engene Holdings (ENGN) | 0.6 | $3.2M | NEW | 352k | 9.03 |
|
| Biontech Se Sponsored Ads (BNTX) | 0.6 | $3.2M | +75% | 33k | 95.20 |
|
| Krystal Biotech (KRYS) | 0.6 | $3.0M | 12k | 246.54 |
|
|
| Ambev Sa Sponsored Adr (ABEV) | 0.5 | $2.6M | +18% | 1.1M | 2.47 |
|
| Zai Lab Adr (ZLAB) | 0.4 | $2.3M | 132k | 17.64 |
|
|
| Crispr Therapeutics Namen Akt (CRSP) | 0.4 | $2.2M | +7% | 43k | 52.44 |
|
| Beam Therapeutics (BEAM) | 0.4 | $2.0M | +17% | 72k | 27.72 |
|
| Lexeo Therapeutics (LXEO) | 0.4 | $1.9M | 193k | 9.93 |
|
|
| Stoke Therapeutics (STOK) | 0.3 | $1.7M | NEW | 55k | 31.74 |
|
| Meiragtx Holdings (MGTX) | 0.3 | $1.6M | +22% | 200k | 7.95 |
|
| 4d Molecular Therapeutics In (FDMT) | 0.3 | $1.6M | +6% | 210k | 7.50 |
|
| SLB Com Stk (SLB) | 0.3 | $1.5M | +97% | 39k | 38.38 |
|
| Moderna (MRNA) | 0.3 | $1.5M | +5% | 50k | 29.49 |
|
| Hims & Hers Health Com Cl A (HIMS) | 0.2 | $1.3M | 40k | 32.47 |
|
|
| Cartesian Therapeutics Com New (RNAC) | 0.2 | $1.2M | NEW | 173k | 7.21 |
|
| Vizsla Silver Corp Com New (VZLA) | 0.2 | $1.1M | 205k | 5.47 |
|
|
| Pfizer (PFE) | 0.2 | $940k | 38k | 24.90 |
|
|
| Sarepta Therapeutics (SRPT) | 0.2 | $925k | NEW | 43k | 21.52 |
|
| Taysha Gene Therapies Com Shs (TSHA) | 0.2 | $907k | +22% | 165k | 5.50 |
|
| Nov (NOV) | 0.2 | $830k | -16% | 53k | 15.63 |
|
| Seabridge Gold (SA) | 0.1 | $703k | -50% | 24k | 29.59 |
|
| Autolus Therapeutics Spon Ads (AUTL) | 0.1 | $649k | +5% | 326k | 1.99 |
|
| Rocket Pharmaceuticals (RCKT) | 0.1 | $597k | -60% | 170k | 3.51 |
|
| Transocean Registered Shs (RIG) | 0.1 | $577k | +36% | 140k | 4.13 |
|
| Sandridge Energy Com New (SD) | 0.1 | $560k | -23% | 39k | 14.43 |
|
| Voyager Therapeutics (VYGR) | 0.1 | $373k | +111% | 95k | 3.93 |
|
| Fate Therapeutics (FATE) | 0.1 | $363k | +10% | 369k | 0.98 |
|
| Valaris Cl A (VAL) | 0.1 | $318k | -24% | 6.3k | 50.40 |
|
| Noble Corp Ord Shs A (NE) | 0.1 | $306k | -24% | 11k | 28.24 |
|
| Sprott Fds Tr Uranium Miners E (URNM) | 0.1 | $297k | -52% | 5.4k | 54.89 |
|
| Tidewater (TDW) | 0.1 | $277k | 5.5k | 50.51 |
|
|
| Nomad Foods Usd Ord Shs (NOMD) | 0.0 | $103k | NEW | 8.2k | 12.51 |
|
Past Filings by Privium Fund Management B.V.
SEC 13F filings are viewable for Privium Fund Management B.V. going back to 2021
- Privium Fund Management B.V. 2025 Q4 filed Feb. 3, 2026
- Privium Fund Management B.V. 2025 Q3 filed Nov. 4, 2025
- Privium Fund Management B.V. 2025 Q2 filed July 30, 2025
- Privium Fund Management B.V. 2025 Q1 filed May 9, 2025
- Privium Fund Management B.V. 2024 Q4 filed Feb. 11, 2025
- Privium Fund Management B.V. 2024 Q3 filed Nov. 1, 2024
- Privium Fund Management B.V. 2024 Q2 filed Aug. 1, 2024
- Privium Fund Management B.V. 2024 Q1 filed April 30, 2024
- Privium Fund Management B.V. 2023 Q4 restated filed Feb. 26, 2024
- Privium Fund Management B.V. 2023 Q3 filed Nov. 6, 2023
- Privium Fund Management B.V. 2023 Q2 filed July 26, 2023
- Privium Fund Management B.V. 2023 Q2 restated filed July 26, 2023
- Privium Fund Management B.V. 2023 Q1 filed May 3, 2023
- Privium Fund Management B.V. 2022 Q4 filed Feb. 3, 2023
- Privium Fund Management B.V. 2022 Q3 filed Nov. 3, 2022
- Privium Fund Management B.V. 2022 Q2 filed July 28, 2022